The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benigni, F.
Right arrow Articles by Mondino, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benigni, F.
Right arrow Articles by Mondino, A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Breast Cancer
The Journal of Immunology, 2005, 175: 739-748.
Copyright © 2005 by The American Association of Immunologists

Phenotype and Homing of CD4 Tumor-Specific T Cells Is Modulated by Tumor Bulk1

Fabio Benigni2,3,*, Valérie S. Zimmermann3,*, Stephanie Hugues4,{dagger}, Stefano Caserta*,{ddagger}, Veronica Basso*, Laura Rivino5,*, Elizabeth Ingulli§, Laurent Malherbe{dagger}, Nicolas Glaichenhaus{dagger} and Anna Mondino6,*

* Cancer Immunotherapy and Gene Therapy Program, S. Raffaele Scientific Institute, Milan, Italy; {dagger} Institut National de la Recherche Médicale, Université de Nice-Sophia Antipolis, Valbonne, France; {ddagger} International Ph.D. Program in Molecular Medicine, University Vita e Salute, Milan, Italy; and § Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455

Technical difficulties in tracking endogenous CD4 T lymphocytes have limited the characterization of tumor-specific CD4 T cell responses. Using fluorescent MHC class II/peptide multimers, we defined the fate of endogenous Leishmania receptor for activated C kinase (LACK)-specific CD4 T cells in mice bearing LACK-expressing TS/A tumors. LACK-specific CD44highCD62Llow CD4 T cells accumulated in the draining lymph nodes and had characteristics of effector cells, secreting IL-2 and IFN-{gamma} upon Ag restimulation. Increased frequencies of CD44highCD62Llow LACK-experienced cells were also detected in the spleen, lung, liver, and tumor itself, but not in nondraining lymph nodes, where the cells maintained a naive phenotype. The absence of systemic redistribution of LACK-specific memory T cells correlated with the presence of tumor. Indeed, LACK-specific CD4 T cells with central memory features (IL-2+IFN-{gamma}CD44highCD62Lhigh cells) accumulated in all peripheral lymph nodes of mice immunized with LACK-pulsed dendritic cells and after tumor resection. Together, our data demonstrate that although tumor-specific CD4 effector T cells producing IFN-{gamma} are continuously generated in the presence of tumor, central memory CD4 T cells accumulate only after tumor resection. Thus, the continuous stimulation of tumor-specific CD4 T cells in tumor-bearing mice appears to hinder the systemic accumulation of central memory CD4 T lymphocytes.




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. A. Nigro, A. T. Brini, E. Soprana, A. Ambrosi, D. Dombrowicz, A. G. Siccardi, and L. Vangelista
Antitumor IgE Adjuvanticity: Key Role of Fc{epsilon}RI
J. Immunol., October 1, 2009; 183(7): 4530 - 4536.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Sportes, F. T. Hakim, S. A. Memon, H. Zhang, K. S. Chua, M. R. Brown, T. A. Fleisher, M. C. Krumlauf, R. R. Babb, C. K. Chow, et al.
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
J. Exp. Med., July 7, 2008; 205(7): 1701 - 1714.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Caserta, P. Alessi, J. Guarnerio, V. Basso, and A. Mondino
Synthetic CD4+ T Cell-Targeted Antigen-Presenting Cells Elicit Protective Antitumor Responses
Cancer Res., April 15, 2008; 68(8): 3010 - 3018.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. S. Zimmermann, A. Casati, C. Schiering, S. Caserta, R. Hess Michelini, V. Basso, and A. Mondino
Tumors Hamper the Immunogenic Competence of CD4+ T Cell-Directed Dendritic Cell Vaccination
J. Immunol., September 1, 2007; 179(5): 2899 - 2909.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. C. Tilton, M. R. Luskin, A. J. Johnson, M. Manion, C. W. Hallahan, J. A. Metcalf, M. McLaughlin, R. T. Davey Jr., and M. Connors
Changes in Paracrine Interleukin-2 Requirement, CCR7 Expression, Frequency, and Cytokine Secretion of Human Immunodeficiency Virus-Specific CD4+ T Cells Are a Consequence of Antigen Load
J. Virol., March 15, 2007; 81(6): 2713 - 2725.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Charalambous, M. Oks, G. Nchinda, S. Yamazaki, and R. M. Steinman
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
J. Immunol., December 15, 2006; 177(12): 8410 - 8421.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.